Tofacitinib and risk of cardiovascular outcomes: results from the Safety of Tofacitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study
Ann Rheum Dis. 2022 Jan 13. Epub ahead of print doi: 10.1136/annrheumdis-2021-221915
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis. 2022 Jan 13. Epub ahead of print doi: 10.1136/annrheumdis-2021-221915
N Engl J Med 2022;386:316–26. doi: 10.1056/NEJMc2202778
Rheumatology (Oxford). 2021. Epub ahead of print. doi: 10.1093/rheumatology/keab740.
Ann Rheum Dis. 2021 Jul 28:annrheumdis-2021-220651
Arthritis Rheumatol. 2021;73(7):1155–66
Ann Rheum Dis. 2021 May 28. DOI: 10.1136/annrheumdis-2021-220418
Wells AF, et al. Rheumatol Ther. 2021. Epub ahead of print. DOI: 10.1007/s40744-021-00317-9.
Int J Clin Pharmacol Ther. 2021. Epub ahead of print.
Rheumatology (Oxford). 2021 Mar 22:keab294. Epub ahead of print. DOI: 10.1093/rheumatology/keab294
Ann Rheum Dis 2021;80:96–102.